{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T01:58:14Z","timestamp":1785290294303,"version":"3.55.0"},"reference-count":0,"publisher":"Therapeutic Guidelines Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aust Prescr"],"DOI":"10.18773\/austprescr.2026.030","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T01:00:22Z","timestamp":1785286822000},"page":"154-155","source":"Crossref","is-referenced-by-count":0,"title":["New Drug: Elafibranor for primary biliary cholangitis"],"prefix":"10.18773","volume":"49","member":"39051","published-online":{"date-parts":[[2026,8,4]]},"container-title":["Australian Prescriber"],"original-title":[],"link":[{"URL":"https:\/\/australianprescriber.tg.org.au\/articles\/elafibranor-for-primary-biliary-cholangitis.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T01:00:23Z","timestamp":1785286823000},"score":1,"resource":{"primary":{"URL":"https:\/\/australianprescriber.tg.org.au\/articles\/elafibranor-for-primary-biliary-cholangitis.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8,4]]}},"URL":"https:\/\/doi.org\/10.18773\/austprescr.2026.030","relation":{},"ISSN":["1839-3942"],"issn-type":[{"value":"1839-3942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]}}}